0001140361-21-020110.txt : 20210607
0001140361-21-020110.hdr.sgml : 20210607
20210607203017
ACCESSION NUMBER: 0001140361-21-020110
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210603
FILED AS OF DATE: 20210607
DATE AS OF CHANGE: 20210607
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Meiers James R.
CENTRAL INDEX KEY: 0001860603
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38594
FILM NUMBER: 211000973
MAIL ADDRESS:
STREET 1: C/O TILRAY, INC.
STREET 2: 745 FIFTH AVENUE, SUITE 160
CITY: NEW YORK
STATE: NY
ZIP: 10151
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tilray, Inc.
CENTRAL INDEX KEY: 0001731348
STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
IRS NUMBER: 824310622
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 745 FIFTH AVENUE
STREET 2: SUITE 1602
CITY: NEW YORK
STATE: NY
ZIP: 10151
BUSINESS PHONE: 519.322.8800
MAIL ADDRESS:
STREET 1: 745 FIFTH AVENUE
STREET 2: SUITE 1602
CITY: NEW YORK
STATE: NY
ZIP: 10151
4
1
form4.xml
FORM 4
X0306
4
2021-06-03
0001731348
Tilray, Inc.
TLRY
0001860603
Meiers James R.
C/O TILRAY, INC.
745 FIFTH AVENUE, SUITE 1602
NEW YORK
NY
10151
true
Head of Canada
Class 2 Common Stock
2021-06-03
4
S
0
23826
19.64
D
0
D
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.54 to $19.70, inclusive. The reporting person undertakes to provide to Tilray, Inc., any security holder of Tilray, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
/s/ Carl A. Merton, as Attorney-in-Fact for James R. Meiers
2021-06-07